Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
1,559 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
SeeLife Impact 2 LLCBiotechnology
Draper, Utah · founded 2025 · Equity · 65 investors · Ronald Wilhelm
SeeLife Impact 6 LLCBiotechnology
Draper, Utah · founded 2025 · Equity · 50 investors · Ronald Wilhelm
SeeLife Impact 3 LLCBiotechnology
Draper, Utah
OS Therapies IncBiotechnology
Grasonville, Maryland · Equity, Options, Convertible · 9 investors · John Ciccio, Avril McKean Dieser
Rhodenergy An Environmental Co CorpBiotechnology
Princeton, New Jersey · founded 2024 · Equity, Debt, Options, Convertible · Irfan Jameel
Iaso Therapeutics, Inc.Biotechnology
East Lansing, Michigan · Options · 1 investors · Steve Kuemmerie, Robert Forgey
Serafin Labs, Inc.Biotechnology
San Diego, California · founded 2024 · Debt, Options, Convertible · 2 investors · Sural Ranamukhaarachchi, Daya Ranamukhaarachchi
SeeLife Impact 5 LLCBiotechnology
Draper, Utah · founded 2025 · Equity · 93 investors · Ronald Wilhelm
Vizgen, Inc.Biotechnology
Waltham, Massachusetts · Equity, Options · 9 investors · Andrea Jackson, Simona Levi
Gasami Therapeutics, Inc.Biotechnology
Richmond, Virginia · founded 2025 · Debt · 1 investors · Sarah Hunter-Chang
Circulate Health, Inc.Biotechnology
Seattle, Washington · founded 2021 · Equity, Options, Convertible · 4 investors · Brad Younggren, Uri Greenwald
GelMEDIX, Inc.Biotechnology
Cambridge, Massachusetts · founded 2020 · Equity · 5 investors · Parinaz Motamedy, Nasim Annabi
Immorta Bio, Inc.Biotechnology
Miami Beach, Florida · founded 2023 · Equity · 3 investors · Boris Reznik
Dermata Therapeutics, Inc.Biotechnology
San Diego, California · founded 2021 · Equity, Options, Convertible · 14 investors · Maria Bedoya Toro Munera, Mary Fisher
Harvard Apparatus Regenerative Technology, Inc.Biotechnology
Holliston, Massachusetts · Equity · 2 investors · William Fodor, Ting Li
MAIA Biotechnology, Inc.Biotechnology
Chicago, Illinois · Equity, Options, Convertible · 17 investors · Sergei Gryaznov, Jean-Manasse Theagene
Digital Biotechnologies, Inc.Biotechnology
Seattle, Washington · founded 2021 · Equity · 61 investors · Harlan Robins, Chad Robins
Alume Biosciences IncBiotechnology
La Jolla, California · Equity · 62 investors · Kaveri Parker, Magda Marquet
Cadrenal Therapeutics, Inc.Biotechnology
Ponte Vedra, Florida · founded 2022 · Options, Convertible · 4 investors · John Murphy, Lee Golden
Genialis, Inc.Biotechnology
Boston, Massachusetts · Debt, Options · 2 investors · Ita Lu, Cedric Odje
IN8BIO, INC.Biotechnology
New York, New York · Equity, Options, Convertible · 17 investors · Luba Greenwood, Lawrence Lamb
DMC Biotechnologies, Inc.Biotechnology
Boulder, Colorado · Equity, Debt, Options, Convertible, Promissory notes convertible into equity sec · 7 investors · Josh Yelen, Josko Bobanovic
DMC Biotechnologies, Inc.Biotechnology
Boulder, Colorado · Equity, Debt, Options, Convertible, Promissory notes convertible into equity sec · 4 investors · Rob van der Meij, Josh Yelen
Tivic Health Systems, Inc.Biotechnology
Fremont, California · Debt, Options, Convertible · 1 investors · Michael Handley, Lisa Wolf
Tivic Health Systems, Inc.Biotechnology
Fremont, California · Equity, Options, Convertible · 5 investors · Jennifer Ernst, Christina Valauri
GEN1E LIFESCIENCES INC.Biotechnology
Palo Alto, California · Equity · 44 investors · Ritu Lal, Francois Nader
Aprea Therapeutics, Inc.Biotechnology
Doylestown, Pennsylvania · Equity, Options, Convertible · 8 investors · John Hamill, Jean-Pierre Bizzari
SLAM BioTherapeutics, Inc.Biotechnology
Westlake Village, California · founded 2022 · Debt, Options, Convertible · 1 investors · Richard Heinick, Ted Schwartz
Mediar Therapeutics, Inc.Biotechnology
Boston, Massachusetts · Equity · 18 investors · Andreas Jurgeit, Bharat Srinivasa
Myrtelle Inc.Biotechnology
New York, New York · founded 2021 · Equity, Exchanging Convertible Notes for Series B-2 Preferred Stock · 21 investors · Thomas Barton, Adrian Stecyk